as on November 17, 2025 at 8:42 pm IST
Day's Low
Day's High
6.60%
Downside
1.77%
Upside
52 Week's Low
52 Week's High
48.63%
Downside
20.61%
Upside
Check Diamedica Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$308.8M
EPS (TTM)
-0.72
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-33.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-64.12%
Compare market cap, revenue, PE, and other key metrics of Diamedica Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $308.8M | 33.26% | NA | 0.00% | |
| BUY | $60.0B | 247.38% | 1448.9 | 1.36% | |
| NA | $43.9B | NA | 717.29 | 1.38% | |
| BUY | $110.9B | 96.07% | 30.76 | 31.35% | |
| BUY | $73.0B | 28.87% | 16.61 | 32.13% |
The Diamedica Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Diamedica Therapeutics Inc investment value today
Current value as on today
₹1,59,954
Returns
₹59,954
(+59.95%)
Returns from Diamedica Therapeutics Inc Stock
₹54,863 (+54.86%)
Dollar Returns*
₹5,091 (+5.09%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Diamedica Therapeutics Inc. Average target price of $15.5
Get share price movements and forecasts by analysts on Diamedica Therapeutics Inc.
What analysts predicted
59.94%UPSIDE
Target Price
$15.5
Current Price
$6.21
Analyzed by
9 Analysts
Target
$15.50
Diamedica Therapeutics Inc target price $15.5, a slight upside of 59.94% compared to current price of $6.21. According to 9 analysts rating.
Search interest for Diamedica Therapeutics Inc Stock has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, DMAC has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 3 years, DMAC stock has moved up by 402.5%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 93.3% return, outperforming this stock by 45.4%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -7.69M → -8.62M (in $), with an average decrease of 12.0% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 30.83M → 13.80M (in $), with an average decrease of 55.2% per quarter
| Organisation | Diamedica Therapeutics Inc |
| Headquarters | 301 Carlson Parkway, Minneapolis, MN, United States, 55305 |
| Industry | Health Technology |
| CEO | Mr. Dietrich John Pauls MBA |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Alex Aimetti Ph.D. | Chief Development Officer |
Dr. Julie Krop M.D. | Chief Medical Officer |
Mr. Dietrich John Pauls MBA | President, CEO & Director |
Mr. Scott Kellen CPA | CFO & Corporate Secretary |
Dr. Ambarish Shah Ph.D. | Chief Technology Officer |
Mr. Dominic R. Cundari | Chief Commercial Officer |
Diamedica Therapeutics Inc share price today is $6.21 as on . Diamedica Therapeutics Inc share today touched a day high of $6.32 and a low of $5.8.
Diamedica Therapeutics Inc share touched a 52 week high of $7.49 on and a 52 week low of $3.19 on . Diamedica Therapeutics Inc stock price today i.e. is trending at $6.21,which is 17.09% down from its 52 week high and 94.67% up from its 52 week low.
Diamedica Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Diamedica Therapeutics Inc (DMAC) shares with as little as ₹88.613 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.13 in Diamedica Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Diamedica Therapeutics Inc share’s latest price of $6.21 as on November 17, 2025 at 8:42 pm IST, you will get 1.6103 shares of Diamedica Therapeutics Inc. Learn more about
fractional shares .
Diamedica Therapeutics Inc stock has given 33.26% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?